top of page
The Sage Group is attending BioEurope in Vienna, Austria, from November 3-5, 2025! Please click here to meet!
See Latest News!
GLOBAL LIFE SCIENCES DEALMAKERS: 30+ YEARS. 300+ CLIENTS & TRANSACTIONS. BILLIONS IN VALUE.
The Sage Group
Why Sage?
About
Track Record
Locations
Added Value
Sage Clients
Testimonials
SAGEIQ
Services
M & A
Licensing
Sage Global
Sage APAC
Sage China
Sage Japan
Sage India
Team
Meet Us!
News
Downloads
Contact
More
Use tab to navigate through the menu items.
Sage Group News
Zumutor – Licensing Opportunity for Next Generation Tumor-Directed Immunotherapeutics Harnessing the Power of NK Cells
Zumutor Biologics is a biotechnology company based in Boston, USA, and Bangalore, India, focused on advancing innovative cancer...
D-PLEX100 from Polypid for Prevention of Surgical Site Infections - Seeking a US Licensing Partner
Our client, PolyPid Ltd. ( PolyPid - Optimized Therapeutics ; NASDAQ:PYPD) has a patented surgical site infection (SSI) prevention...
Sage Group Advises Evecxia on Licensing of EVX-101, a Novel Treatment for Depression and OCD Using Serotonin Synthesis Amplification
Evecxia deploys 5-hydroxytryptophan, 5-HTP, to achieve Serotonin Synthesis Amplification. 5-HTP amplifies brain serotonin and have shown...
bottom of page
